Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity

Cell Discovery

Volumn 2, Issue , 2016, Pages

  Sun, Weijia ^a,b   Zhao, Chenyang ^a,b,c   Li, Yuheng ^a   Wang, Liang ^d   Nie, Guangjun ^e   Peng, Jiang ^f   Wang, Aiyuan ^f   Zhang, Pengfei ^a,b   Tian, Weiming ^g   Li, Qi ^a   Song, Jinping ^a   Wang, Cheng ^f   Xu, Xiaolong ^f   Tian, Yanhua ^e   Zhao, Dingsheng ^a   Xu, Zi ^a,b   Zhong, Guohui ^a   Han, Bingxing ^a   Ling, Shukuan ^a   Chang, Yan Zhong ^b   Li, Yingxian ^a   more..

^a China Astronaut Research and Training Center   (China)

^b HEBEI NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d Chinese Peoples Liberation Army General Hospital   (China)

^e NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^f CHINESE PLA GENERAL HOSPITAL   (China)

^g HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

exosome; miRNA; osteoblast; osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; EPHRIN A2; EPHRIN RECEPTOR A2; MICRORNA 214; OSTEOCLAST DIFFERENTIATION FACTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COMMUNICATION; CELL FUNCTION; CELLULAR SECRETION; COCULTURE; EXOSOME; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAW 264.7 CELL LINE; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

EID: 85001682075     PISSN: None     EISSN: 20565968     Source Type: Journal    
DOI: 10.1038/celldisc.2016.15     Document Type: Article

References (68)

1. Del Fattore A, Teti A, Rucci N. Osteoclast receptors and signaling. Arch Biochem Biophys 2008; 473: 147-160.
2. Ross FP, Teitelbaum SL. Alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev 2005; 208: 88-105.
3. Miyazaki T, Tanaka S, Sanjay A, Baron R. The role of c-Src kinase in the regulation of osteoclast function. Mod Rheumatol 2006; 16: 68-74.
4. Edwards CM, Mundy GR. Eph receptors and ephrin signaling pathways: a role in bone homeostasis. Int J Med Sci 2008; 5: 263-272.
5. Sims NA, Gooi JH. Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008; 19: 444-451.
6. Nakashima T, Hayashi M, Fukunaga T et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011; 17: 1231-1234.
7. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-357.
8. Zhao C, Irie N, Takada Y et al. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 2006; 4: 111-121.
9. Negishi-Koga T, Shinohara M, Komatsu N et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med 2011; 17: 1473-1480.
10. Sims NA, Martin TJ. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. Bonekey Rep 2014; 3: 481.
11. Matsuo K, Otaki N. Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr 2012; 6: 148-156.
12. Lian JB, Stein GS, van Wijnen AJ et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212-227.
13. Lawrie CH, Gal S, Dunlop HM et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675.
14. Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
15. Hanke M, Hoefig K, Merz H et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010; 28: 655-661.
16. Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983; 33: 967-978.
17. Thery C, Regnault A, Garin J et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999; 147: 599-610.
18. Raposo G, Nijman HW, Stoorvogel W et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996; 183: 1161-1172.
19. Blanchard N, Lankar D, Faure F et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 2002; 168: 3235-3241.
20. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 1997; 8: 2631-2645.
21. van Niel G, Raposo G, Candalh C et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001; 121: 337-349.
22. Mears R, Craven RA, Hanrahan S et al. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 2004; 4: 4019-4031.
23. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
24. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007; 67: 2912-2915.
25. Beninson LA, Fleshner M. Exosomes: an emerging factor in stress-induced immunomodulation. Semin Immunol 2014; 26: 394-401.
26. Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 2013; 92: 387-397.
27. Lee JK, Park SR, Jung BK et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by downregulating VEGF expression in breast cancer cells. PLoS ONE 2013; 8: e84256.
28. Hergenreider E, Heydt S, Tréguer K et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012; 14: 249-256.
29. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
30. Ohno S, Takanashi M, Sudo K et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 2013; 21: 185-191.
31. Montecalvo A, Larregina AT, Shufesky WJ et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012; 119: 756-766.
32. Katsuda T, Ikeda S, Yoshioka Y, Kosaka N, Kawamata M, Ochiya T. Physiological and pathological relevance of secretory microRNAs and a perspective on their clinical application. Biol Chem 2014; 395: 365-373.
33. Penna E, Orso F, Cimino D et al. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011; 30: 1990-2007.
34. Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol 2012; 44: 2060-2064.
35. Mittelbrunn M, Sanchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 2012; 13: 328-335.
36. Sugatani T, Vacher J, Hruska KA. A microRNA expression signature of osteoclastogenesis. Blood 2011; 117: 3648-3657.
37. Ell B, Mercatali L, Ibrahim T et al. Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis. Cancer Cell 2013; 24: 542-556.
38. Cheng C, Chen ZQ, Shi XT. MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase. Tumour Biol 2014; 35: 4177-4183.
39. Cheng P, Chen C, He HB et al. miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 2013; 28: 1180-1190.
40. Zhu J, Feng Y, Ke Z et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol 2012; 180: 2440-2451.
41. Li X, Kroin JS, Kc R et al. Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res 2013; 28: 2512-2522.
42. Wang X, Guo B, Li Q et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med 2013; 19: 93-100.
43. Schoolmeesters A, Eklund T, Leake D et al. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE 2009; 4: e5605.
44. Palmieri A, Pezzetti F, Brunelli G et al. Anorganic bovine bone (Bio-Oss) regulates miRNA of osteoblast-like cells. Int J Periodont Restor Dent 2010; 30: 83-87.
45. Pan W, Wang H, Jianwei R, Ye Z. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem 2014; 33: 402-412.
46. Guo D, Li Q, Lv Q, Wei Q, Cao S, Gu J. MiR-27a targets sFRP1 in hFOB cells to regulate proliferation, apoptosis and differentiation. PLoS ONE 2014; 9: e91354.
47. Penzkofer D, Bonauer A, Fischer A et al. Phenotypic characterization of miR-92a -/- mice reveals an important function of miR-92a in skeletal development. PLoS ONE 2014; 9: e101153.
48. Hassan MQ, Gordon JA, Beloti MM et al. A network connecting Runx2, SATB2, and the miR-23a-27a-24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 2010; 107: 19879-19884.
49. Jones KB, Salah Z, Del Mare S et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72: 1865-1877.
50. Eguchi T, Watanabe K, Hara ES, Ono M, Kuboki T, Calderwood SK. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS ONE 2013; 8: e58796.
51. Bluml S, Bonelli M, Niederreiter B et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum 2011; 63: 1281-1288.
52. Suomi S, Taipaleenmaki H, Seppanen A et al. MicroRNAs regulate osteogenesis and chondrogenesis of mouse bone marrow stromal cells. Gene Regul Syst Biol 2008; 2: 177-191.
53. Watanabe T, Sato T, Amano T et al. Dnm3os, a non-coding RNA, is required for normal growth and skeletal development in mice. Dev Dyn 2008; 237: 3738-3748.
54. Guo LJ, Liao L, Yang L, Li Y, Jiang TJ. MiR-125a TNF receptor-associated factor 6 to inhibit osteoclastogenesis. Exp Cell Res 2014; 321: 142-152.
55. Zhao C, Sun W, Zhang P et al. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol 2015; 12: 343-353.
56. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-17452.
57. Irie N, Takada Y, Watanabe Y et al. Bidirectional signaling through EphrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 2009; 284: 14637-14644.
58. Li J, Liu K, Liu Y et al. Exosomes mediate the cell-to-cell transmission of IFN-alpha-induced antiviral activity. Nat Immunol 2013; 14: 793-803.
59. Noren NK, Pasquale EB. Eph receptor-ephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 2004; 16: 655-666.
60. Kariya Y, Honma M, Hanamura A et al. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells. J Bone Miner Res 2011; 26: 689-703.
61. Shimada-Sugawara M, Sakai E, Okamoto K et al. Rab27A regulates transport of cell surface receptors modulating multinucleation and lysosome-related organelles in osteoclasts. Scientific Rep 2015; 5: 9620.
62. Panach L, Mifsut D, Tarin JJ, Cano A, Garcia-Perez MA. Serum circulating microRNAs as biomarkers of osteoporotic fracture. Calcif Tissue Int 2015; 97: 495-505.
63. Weilner S, Skalicky S, Salzer B et al. Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone 2015; 79: 43-51.
64. Seeliger C, Karpinski K, Haug AT et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res 2014; 29: 1718-1728.
65. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006; 30:3.22:3.22.1-3.22.29.
66. Dai S, Wan T, Wang B et al. More efficient induction of HLA-A∗0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res 2005; 11: 7554-7563.
67. Wang H, Wu Y, Zhao R, Nie G. Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy. Adv Mater 2013; 25: 1616-1622.
68. Wang H, Zhao Y, Wu Y et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 2011; 32: 8281-8290.